Komori
Adjuvant Holdings (4929) · TargetRestated

Global Strategy Rollout

First written in FY2016. 5 of 7 entries say "Restated". Latest entry: FY2026.

7entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019RestatedFY2023 – FY20262016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 120222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies

134 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 220 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The Company intends to use retained earnings to increase cost competitiveness beyond previous levels in response to anticipated changes in the business environment, strengthen its product development structure and sales-office network to meet market needs, and make effective investments to advance its global strategy.」

    The company is reaffirming its policies on the product development structure, expansion of sales offices and use of retained earnings for its global strategy.
  2. FY2023RestatedAnnual report

    「We recognize that the top priority for our Group at present is to expand our share of the domestic market, and for the time being we will concentrate our management resources on the domestic market. In overseas markets, we will work to rebuild our sales channels while taking into account progress on our top priority.」

    The company continues to pursue a policy of placing the highest priority on the domestic market and positioning overseas operations as an effort to rebuild sales channels.
  3. FY2022SoftenedAnnual report

    「We recognize that the top priority for our Group at present is to expand our share of the domestic market, and for the time being we will concentrate our management resources on the domestic market. In overseas markets, we will work to rebuild our sales channels while taking into account progress on our top priority.」

    Compared with the previous global expansion policy, the company currently places the highest priority on the domestic market and positions overseas operations as an effort to rebuild sales channels.
  4. FY2019RestatedAnnual report

    「The Company will increase opportunities to approach Southeast Asia from its base in Hong Kong and promote Ajuban cosmetics.」

    The company continues to pursue expansion into Southeast Asia from a base in Hong Kong as a specific direction for its global strategy.
  5. FY2018RestatedAnnual report

    「The Company will increase opportunities to approach Southeast Asia from its base in Hong Kong and promote Ajuban cosmetics.」

    The company presents expansion into Southeast Asia from a base in Hong Kong as a specific direction for its global strategy, for which the use of retained earnings had been identified as an investment purpose.
  6. FY2017RestatedAnnual report

    「The Company intends to use retained earnings to increase cost competitiveness beyond previous levels in response to anticipated changes in the business environment, strengthen its product development structure and sales-office network to meet market needs, and make effective investments to advance its global strategy.」

    The Company continues to identify investment in product development, sales-office expansion and its global strategy as uses of retained earnings.
  7. FY2016First statedAnnual report

    「The Company intends to allocate funds to effective investments to advance its global strategy.」

    The Company identifies its global strategy as a use of retained earnings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.